Vedolizumab for the Treatment of IBD: A Selective Therapeutic Approach Targeting Pathogenic a4b7 Cells

Manol Jovani, Silvio Danese
  • Current Drug Targets, October 2013, Bentham Science Publishers
  • DOI: 10.2174/13894501113146660206

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr Manol Jovani

In partnership with: